Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo.
Lamour V, Henry A, Kroonen J, Nokin MJ, von Marschall Z, Fisher LW, Chau TL, Chariot A, Sanson M, Delattre JY, Turtoi A, Peulen O, Rogister B, Castronovo V, Bellahcène A.
Lamour V, et al. Among authors: peulen o.
Int J Cancer. 2015 Sep 1;137(5):1047-57. doi: 10.1002/ijc.29454. Epub 2015 May 21.
Int J Cancer. 2015.
PMID: 25620078